This website uses cookies to give you the best user experience. If you continue
without changing your settings we'll assume you are happy to receive all RSC cookies.
You can change your cookie settings by navigating to our Privacy and Cookies page and following the instructions. These instructions
are also obtainable from the privacy link at the bottom of any RSC page.
International Centre for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi 110067, India
E-mail: virander@icgeb.res.in
; Fax: +91-11-26742316
; Tel: +91-11-26741358
b
Department of Physics, Indian Institute of Science, Bangalore 560012, India
E-mail: ramak@physics.iisc.ernet.in
; Tel: +91-80-22932312
Chem. Commun., 2013,49, 2688-2690
DOI:
10.1039/C3CC38982K
Received
16 Dec 2012,
Accepted
11 Feb 2013
First published online
13 Feb 2013
hIAPP fibrillization implicated in Type 2 diabetes pathology involves formation of oligomers toxic to insulin producing pancreatic β-cells. We report design, synthesis, 3D structure and functional characterization of dehydrophenylalanine (ΔF) containing peptides which inhibit hIAPP fibrillization. The inhibitor protects β-cells from hIAPP induced toxicity.
Fetching data from CrossRef. This may take some time to load.